{"transactions":[{"id":747883,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:24:25.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001640069-26-000002","document":"form4-06052026_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000164006926000002/form4-06052026_080621.xml","form_type":"4"}},{"id":1122850,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-05T00:32:00.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":29747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2026 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":29747,"derivative":{"exercise_price":10.9,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":29747},"source":{"system":"sec-edgar","filing":"0001415889-25-015695","document":"form4-06052025_120657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588925015695/form4-06052025_120657.xml","form_type":"4"}},{"id":1486725,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-06-07T20:29:20.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":7639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 5, 2025 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":7639,"derivative":{"exercise_price":16.41,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":7639},"source":{"system":"sec-edgar","filing":"0001415889-24-015976","document":"form4-06072024_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000141588924015976/form4-06072024_080616.xml","form_type":"4"}},{"id":1854284,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-06-15T22:22:38.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":19441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall fully vest on June 13, 2024 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date."}],"balance_after":19441,"derivative":{"exercise_price":12.46,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":19441},"source":{"system":"sec-edgar","filing":"0001209191-23-037529","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919123037529/doc4.xml","form_type":"4"}},{"id":2239117,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-08T21:00:45.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":12.96,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-22-035078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919122035078/doc4.xml","form_type":"4"}},{"id":2654762,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-25T20:56:14.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":11650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall fully vest on June 8, 2022 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's  continued service on such  vesting date."}],"balance_after":11650,"derivative":{"exercise_price":40.37,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":11650},"source":{"system":"sec-edgar","filing":"0001209191-21-043329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919121043329/doc4.xml","form_type":"4"}},{"id":3120382,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-05T21:12:16.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":14777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall fully vest on June 3, 2021 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's  continued service on such  vesting date."}],"balance_after":14777,"derivative":{"exercise_price":26.53,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":14777},"source":{"system":"sec-edgar","filing":"0001209191-20-034723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000120919120034723/doc4.xml","form_type":"4"}},{"id":3416257,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-09-13T00:08:39.000Z","date":"2019-09-10","kind":"grant","acquired":true,"shares":29555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest (i) 1/12th of the total shares on June 21, 2019; and then (ii) quarterly as to 1/12th of the total shares, commencing the first quarter following June 21, 2019, subject to reporting person's continued service through each vesting date."}],"balance_after":29555,"derivative":{"exercise_price":28.8,"expiration_date":"2029-09-09","underlying":"Common Stock","underlying_shares":29555},"source":{"system":"sec-edgar","filing":"0001567619-19-018223","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000156761919018223/doc1.xml","form_type":"4"}},{"id":3653141,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-15T09:07:50.000Z","date":"2019-02-15","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":235,"value":4700000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 5, 2019, between Eli Lilly and Company, an Indiana corporation (\"Lilly\"), Bowfin Acquisition Corporation, Inc., a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), and Loxo Oncology, Inc., a Delaware corporation (\"Loxo Oncology\"), Merger Sub will merge with and into Loxo Oncology, with Loxo Oncology surviving as a wholly owned subsidiary of Lilly (the \"Merger\"). Pursuant to the Merger Agreement each issued and outstanding shares (the \"Shares\") of Loxo common stock, par value $0.0001 per share, was purchased at a price of $235.00 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":139.77,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-19-004567","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761919004567/doc1.xml","form_type":"4"}},{"id":3653140,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-15T09:07:50.000Z","date":"2019-02-15","kind":"disposition_to_issuer","acquired":false,"shares":40000,"price":235,"value":9400000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 5, 2019, between Eli Lilly and Company, an Indiana corporation (\"Lilly\"), Bowfin Acquisition Corporation, Inc., a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), and Loxo Oncology, Inc., a Delaware corporation (\"Loxo Oncology\"), Merger Sub will merge with and into Loxo Oncology, with Loxo Oncology surviving as a wholly owned subsidiary of Lilly (the \"Merger\"). Pursuant to the Merger Agreement each issued and outstanding shares (the \"Shares\") of Loxo common stock, par value $0.0001 per share, was purchased at a price of $235.00 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":84.88,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001567619-19-004567","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761919004567/doc1.xml","form_type":"4"}},{"id":3653139,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-15T09:07:50.000Z","date":"2019-02-15","kind":"disposition_to_issuer","acquired":false,"shares":12000,"price":235,"value":2820000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 5, 2019, between Eli Lilly and Company, an Indiana corporation (\"Lilly\"), Bowfin Acquisition Corporation, Inc., a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), and Loxo Oncology, Inc., a Delaware corporation (\"Loxo Oncology\"), Merger Sub will merge with and into Loxo Oncology, with Loxo Oncology surviving as a wholly owned subsidiary of Lilly (the \"Merger\"). Pursuant to the Merger Agreement each issued and outstanding shares (the \"Shares\") of Loxo common stock, par value $0.0001 per share, was purchased at a price of $235.00 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":43.56,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-19-004567","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761919004567/doc1.xml","form_type":"4"}},{"id":3653138,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-15T09:07:50.000Z","date":"2019-02-15","kind":"disposition_to_issuer","acquired":false,"shares":28000,"price":235,"value":6580000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 5, 2019, between Eli Lilly and Company, an Indiana corporation (\"Lilly\"), Bowfin Acquisition Corporation, Inc., a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), and Loxo Oncology, Inc., a Delaware corporation (\"Loxo Oncology\"), Merger Sub will merge with and into Loxo Oncology, with Loxo Oncology surviving as a wholly owned subsidiary of Lilly (the \"Merger\"). Pursuant to the Merger Agreement each issued and outstanding shares (the \"Shares\") of Loxo common stock, par value $0.0001 per share, was purchased at a price of $235.00 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":31.69,"expiration_date":"2025-12-15","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001567619-19-004567","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761919004567/doc1.xml","form_type":"4"}},{"id":3653137,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-15T09:07:50.000Z","date":"2019-02-15","kind":"disposition_to_issuer","acquired":false,"shares":28000,"price":235,"value":6580000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 5, 2019, between Eli Lilly and Company, an Indiana corporation (\"Lilly\"), Bowfin Acquisition Corporation, Inc., a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), and Loxo Oncology, Inc., a Delaware corporation (\"Loxo Oncology\"), Merger Sub will merge with and into Loxo Oncology, with Loxo Oncology surviving as a wholly owned subsidiary of Lilly (the \"Merger\"). Pursuant to the Merger Agreement each issued and outstanding shares (the \"Shares\") of Loxo common stock, par value $0.0001 per share, was purchased at a price of $235.00 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":26.27,"expiration_date":"2026-12-05","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001567619-19-004567","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761919004567/doc1.xml","form_type":"4"}},{"id":3653136,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-15T09:07:50.000Z","date":"2019-02-15","kind":"disposition_to_issuer","acquired":false,"shares":17500,"price":235,"value":4112500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 5, 2019, between Eli Lilly and Company, an Indiana corporation (\"Lilly\"), Bowfin Acquisition Corporation, Inc., a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), and Loxo Oncology, Inc., a Delaware corporation (\"Loxo Oncology\"), Merger Sub will merge with and into Loxo Oncology, with Loxo Oncology surviving as a wholly owned subsidiary of Lilly (the \"Merger\"). Pursuant to the Merger Agreement each issued and outstanding shares (the \"Shares\") of Loxo common stock, par value $0.0001 per share, was purchased at a price of $235.00 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each Loxo Oncology stock option that is then-outstanding and unvested shall become immediately vested and exercisable in full. At the Effective Time, each Loxo Oncology stock option that is outstanding under the Loxo Oncology Equity Incentive Plans (including any unvested Loxo stock options for which the vesting was accelerated immediately prior to the Effective Time as described above) will be cancelled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option. Any outstanding option with an exercise price equal to or greater than the Offer Price will be cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001567619-19-004567","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761919004567/doc1.xml","form_type":"4"}},{"id":3712615,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-02T17:06:26.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 1/48th of the total number of shares on February 2, 2019, then an additional 1/48th vests on each monthly anniversary thereafter, until such time as the option is 100% vested, subject to the reporting person's continued service through each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":139.77,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-19-000103","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761919000103/doc1.xml","form_type":"4"}},{"id":3733661,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, May 1, 2015, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":17500,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733660,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-10","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, May 1, 2015, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":18750,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733659,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-11","kind":"sale","acquired":false,"shares":100,"price":140.48,"value":14048.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733658,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-11","kind":"sale","acquired":false,"shares":100,"price":139.36,"value":13936.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733657,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-11","kind":"sale","acquired":false,"shares":263,"price":137.88,"value":36262.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.50 to $138.05 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733656,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-11","kind":"sale","acquired":false,"shares":587,"price":136.98,"value":80407.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.45 to $137.39 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":463,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733655,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-11","kind":"sale","acquired":false,"shares":200,"price":135.69,"value":27138.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.28 to $136.09 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1050,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733654,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733653,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-10","kind":"sale","acquired":false,"shares":100,"price":136.04,"value":13604.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733652,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-10","kind":"sale","acquired":false,"shares":550,"price":134.71,"value":74090.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.40 to $135.06 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733651,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-10","kind":"sale","acquired":false,"shares":100,"price":133.34,"value":13334.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":650,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733650,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-10","kind":"sale","acquired":false,"shares":400,"price":132.44,"value":52976.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.20 to $132.85 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733649,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-10","kind":"sale","acquired":false,"shares":100,"price":130.79,"value":13079.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1150,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3733648,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-12-12T17:14:53.000Z","date":"2018-12-10","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-007785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007785/doc1.xml","form_type":"4"}},{"id":3750014,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-27","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":20000,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750013,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-26","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":21250,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750012,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":100,"price":151.55,"value":15155.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750011,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":100,"price":148.2,"value":14820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.13 to $148.24 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750010,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":100,"price":147.09,"value":14709.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750009,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":200,"price":143.84,"value":28768.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.54 to $144.14 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750008,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":200,"price":140.94,"value":28188.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.64 to $141.24 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750007,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":350,"price":138.95,"value":48632.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.68 to $139.10 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750006,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":200,"price":137.89,"value":27578.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.63 to $138.15 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1050,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750005,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-27","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750004,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-26","kind":"sale","acquired":false,"shares":100,"price":156.04,"value":15604.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750003,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-26","kind":"sale","acquired":false,"shares":300,"price":155.13,"value":46539.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.69 to $155.37. per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750002,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-26","kind":"sale","acquired":false,"shares":100,"price":153.3,"value":15330.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750001,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-26","kind":"sale","acquired":false,"shares":250,"price":152.39,"value":38097.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.21 to $152.61 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3750000,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-26","kind":"sale","acquired":false,"shares":500,"price":151.57,"value":75785.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.09 to $152.08 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3749999,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-11-28T17:09:50.000Z","date":"2018-11-26","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-007048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918007048/doc1.xml","form_type":"4"}},{"id":3795756,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-04","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":22500,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795755,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-03","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":23750,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795754,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-04","kind":"sale","acquired":false,"shares":200,"price":165.05,"value":33010.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795753,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-04","kind":"sale","acquired":false,"shares":200,"price":164.25,"value":32850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.01 to $164.49 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795752,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-04","kind":"sale","acquired":false,"shares":311,"price":162.5366,"value":50548.8826,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.13 to $162.75 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795751,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-04","kind":"sale","acquired":false,"shares":539,"price":161.2155,"value":86895.1545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.62 to $161.57 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":711,"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795750,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-04","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795749,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-03","kind":"sale","acquired":false,"shares":560,"price":168.9723,"value":94624.488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.35 to $169.27 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795748,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-03","kind":"sale","acquired":false,"shares":100,"price":167.1,"value":16710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":560,"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795747,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-03","kind":"sale","acquired":false,"shares":590,"price":165.5278,"value":97661.402,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.08 to $165.86 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":660,"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3795746,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-10-05T16:44:16.000Z","date":"2018-10-03","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-003760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918003760/doc1.xml","form_type":"4"}},{"id":3815227,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":25000,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3815226,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-12","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":26250,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3815225,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":500,"price":166.756,"value":83378.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.56 to $167.5599 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3815224,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":750,"price":165.5267,"value":124145.025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.12 to $166.1199 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3815223,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-13","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3815222,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":300,"price":170.95,"value":51285.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.90 to $171.8999 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3815221,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":200,"price":168.785,"value":33757.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.78 to $169.7799 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3815220,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":200,"price":167.25,"value":33450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.25 to $168.2499 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3815219,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":550,"price":166.1391,"value":91376.505,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.63 to $166.6299 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3815218,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-09-14T18:19:18.000Z","date":"2018-09-12","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-002678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918002678/doc1.xml","form_type":"4"}},{"id":3843020,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-08-15T17:25:33.000Z","date":"2018-08-14","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":27500,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-001207","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918001207/doc1.xml","form_type":"4"}},{"id":3843019,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-08-15T17:25:33.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":28750,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-18-001207","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918001207/doc1.xml","form_type":"4"}},{"id":3843018,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-08-15T17:25:33.000Z","date":"2018-08-14","kind":"sale","acquired":false,"shares":800,"price":160.6488,"value":128519.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.28 to $161.14 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-001207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918001207/doc1.xml","form_type":"4"}},{"id":3843017,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-08-15T17:25:33.000Z","date":"2018-08-14","kind":"sale","acquired":false,"shares":450,"price":159.4656,"value":71759.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.21 to $159.96 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001567619-18-001207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918001207/doc1.xml","form_type":"4"}},{"id":3843016,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-08-15T17:25:33.000Z","date":"2018-08-14","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-001207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918001207/doc1.xml","form_type":"4"}},{"id":3843015,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-08-15T17:25:33.000Z","date":"2018-08-13","kind":"sale","acquired":false,"shares":10,"price":160.17,"value":1601.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-001207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918001207/doc1.xml","form_type":"4"}},{"id":3843014,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-08-15T17:25:33.000Z","date":"2018-08-13","kind":"sale","acquired":false,"shares":440,"price":158.6882,"value":69822.808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.47 to $159.17 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10,"source":{"system":"sec-edgar","filing":"0001567619-18-001207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918001207/doc1.xml","form_type":"4"}},{"id":3843013,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-08-15T17:25:33.000Z","date":"2018-08-13","kind":"sale","acquired":false,"shares":800,"price":158.0025,"value":126402.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.47 to $158.26 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":450,"source":{"system":"sec-edgar","filing":"0001567619-18-001207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918001207/doc1.xml","form_type":"4"}},{"id":3843012,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-08-15T17:25:33.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":1250,"price":11.35,"value":14187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001567619-18-001207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000156761918001207/doc1.xml","form_type":"4"}},{"id":3869108,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-07-11T17:04:55.000Z","date":"2018-07-09","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":30000,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001140361-18-032164","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118032164/doc1.xml","form_type":"4"}},{"id":3869107,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-07-11T17:04:55.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":100,"price":191.64,"value":19164.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-18-032164","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118032164/doc1.xml","form_type":"4"}},{"id":3869106,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-07-11T17:04:55.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":100,"price":189.12,"value":18912.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001140361-18-032164","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118032164/doc1.xml","form_type":"4"}},{"id":3869105,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-07-11T17:04:55.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":600,"price":187.5283,"value":112516.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $187.23 to $188.04 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001140361-18-032164","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118032164/doc1.xml","form_type":"4"}},{"id":3869104,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-07-11T17:04:55.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":500,"price":186.666,"value":93333.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $186.12 to $186.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001140361-18-032164","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118032164/doc1.xml","form_type":"4"}},{"id":3869103,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-07-11T17:04:55.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":200,"price":184.72,"value":36944.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001140361-18-032164","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118032164/doc1.xml","form_type":"4"}},{"id":3869102,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-07-11T17:04:55.000Z","date":"2018-07-09","kind":"exercise","acquired":true,"shares":1500,"price":11.35,"value":17025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001140361-18-032164","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118032164/doc1.xml","form_type":"4"}},{"id":3885838,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-06-21T17:04:55.000Z","date":"2018-06-19","kind":"exercise","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":31500,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001140361-18-029489","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118029489/doc1.xml","form_type":"4"}},{"id":3885837,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-06-21T17:04:55.000Z","date":"2018-06-19","kind":"sale","acquired":false,"shares":400,"price":178.2025,"value":71281.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $178.02 to $178.43 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-18-029489","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118029489/doc1.xml","form_type":"4"}},{"id":3885836,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-06-21T17:04:55.000Z","date":"2018-06-19","kind":"sale","acquired":false,"shares":500,"price":177.15,"value":88575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $176.96 to $177.30 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001140361-18-029489","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118029489/doc1.xml","form_type":"4"}},{"id":3885835,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-06-21T17:04:55.000Z","date":"2018-06-19","kind":"sale","acquired":false,"shares":800,"price":176.2898,"value":141031.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $175.93 to $176.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":900,"source":{"system":"sec-edgar","filing":"0001140361-18-029489","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118029489/doc1.xml","form_type":"4"}},{"id":3885834,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-06-21T17:04:55.000Z","date":"2018-06-19","kind":"exercise","acquired":true,"shares":1700,"price":11.35,"value":19295.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1700,"source":{"system":"sec-edgar","filing":"0001140361-18-029489","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118029489/doc1.xml","form_type":"4"}},{"id":3930241,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-16T16:45:45.000Z","date":"2018-05-14","kind":"exercise","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":33200,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001140361-18-024223","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118024223/doc1.xml","form_type":"4"}},{"id":3930240,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-05-16T16:45:45.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":290,"price":139.0865,"value":40335.085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $139.00 to $139.22 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-18-024223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118024223/doc1.xml","form_type":"4"}},{"id":3930239,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-05-16T16:45:45.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":210,"price":138.1881,"value":29019.501,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $137.81 to $138.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":290,"source":{"system":"sec-edgar","filing":"0001140361-18-024223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118024223/doc1.xml","form_type":"4"}},{"id":3930238,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-05-16T16:45:45.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":700,"price":137.3289,"value":96130.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $136.81 to $137.62 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001140361-18-024223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118024223/doc1.xml","form_type":"4"}},{"id":3930237,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-05-16T16:45:45.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":300,"price":135.0933,"value":40527.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $135.01 to $135.22 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0001140361-18-024223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118024223/doc1.xml","form_type":"4"}},{"id":3930236,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-05-16T16:45:45.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":200,"price":133.855,"value":26771.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $133.46 to $134.25 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001140361-18-024223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118024223/doc1.xml","form_type":"4"}},{"id":3930235,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-05-16T16:45:45.000Z","date":"2018-05-14","kind":"exercise","acquired":true,"shares":1700,"price":11.35,"value":19295.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1700,"source":{"system":"sec-edgar","filing":"0001140361-18-024223","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118024223/doc1.xml","form_type":"4"}},{"id":3955920,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-04-26T16:33:04.000Z","date":"2018-04-24","kind":"exercise","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments."}],"balance_after":34900,"derivative":{"exercise_price":11.35,"expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001140361-18-019774","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118019774/doc1.xml","form_type":"4"}},{"id":3955919,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-04-26T16:33:04.000Z","date":"2018-04-24","kind":"sale","acquired":false,"shares":300,"price":133.6233,"value":40086.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $133.48 to $133.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-18-019774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118019774/doc1.xml","form_type":"4"}},{"id":3955918,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-04-26T16:33:04.000Z","date":"2018-04-24","kind":"sale","acquired":false,"shares":800,"price":132.0625,"value":105650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $131.51 to $132.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001140361-18-019774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118019774/doc1.xml","form_type":"4"}},{"id":3955917,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-04-26T16:33:04.000Z","date":"2018-04-24","kind":"sale","acquired":false,"shares":300,"price":130.77,"value":39231.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $130.41 to $130.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1100,"source":{"system":"sec-edgar","filing":"0001140361-18-019774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118019774/doc1.xml","form_type":"4"}},{"id":3955916,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-04-26T16:33:04.000Z","date":"2018-04-24","kind":"sale","acquired":false,"shares":300,"price":129.4551,"value":38836.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the aggregate of sales effected on the same day at different prices."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $129.38 to $129.62 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001140361-18-019774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118019774/doc1.xml","form_type":"4"}},{"id":3955915,"issuer":{"id":160155,"kind":"organization","name":"Loxo Oncology, Inc.","symbol":"LOXO"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP of Finance"}}],"security":"Common Stock","published_at":"2018-04-26T16:33:04.000Z","date":"2018-04-24","kind":"exercise","acquired":true,"shares":1700,"price":11.35,"value":19295.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1700,"source":{"system":"sec-edgar","filing":"0001140361-18-019774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581720/000114036118019774/doc1.xml","form_type":"4"}}],"next_cursor":"2018-04-26T16:33:04.000000Z,3955915"}